Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
pharmacokinetics/pharmacodynamics
Pharmacokinetics (PK) and pharmacodynamics (PD) are central for understanding drug behavior, including how drugs moves through the body and how they act, thus laying the foundation for the development of safe and effective drugs.
We offer comprehensive services for preclinical pharmacokinetic and pharmacodynamic studies. PK studies define how the body handles a drug, while PD studies show how the drug affects the body. PK/PD modeling , when combined, provides a powerful tool to predict efficacy, optimize dosing, and guide first-in-human strategies. This approach helps reduce the risk of failure in later stages.
Our team supports tailored study design, dosing strategies, a wide range of bioanalytical methods, and in-house assay development. Using Phoenix WinNonlin®, we perform noncompartmental analysis (NCA) to calculate key PK parameters and optimize subsequent studies by predictive strategies. We link the PK to PD readouts, supporting data-driven decisions at every stage. We adhere to high internal standards to ensure data quality and reproducibility.
Why choose us?
• Integrated PK/PD strategy for better dose selection
• In-house bioanalytical methods development
• Noncompartmental analysis and simulation with WinNonlin®
• Tailored study design and interpretation support
• Transparent, collaborative project management
• Accelerated turnaround for early-phase success
Partner with us to unlock the full value of PK/PD in your development journey.
